NEXI Insider Trading Activity and SEC Form 4 Filings
NEXI insider trading summary
No open-market insider purchases or sales of NexImmune, Inc. (NEXI) have been reported on SEC Form 4 in the past 12 months.
Latest NEXI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 11, 2024 | Kristi Jones | President and CEO | Buy | $0 (1 @ $0.01) |
| Nov 22, 2023 | Alan S. Roemer | Director | Sell | $8K (3,992 @ $1.94) |
| Nov 21, 2023 | Alan S. Roemer | Director | Sell | $8K (3,833 @ $2.16) |
| Mar 30, 2023 | Sol J Barer | Director | Buy | $164K (400,000 @ $0.41) |
| Nov 17, 2022 | Sol J Barer | Director | Buy | $36K (75,000 @ $0.48) |
| Nov 16, 2022 | Sol J Barer | Director | Buy | $60K (125,000 @ $0.48) |
| Jun 7, 2022 | Grant Verstandig | Director | Buy | $61K (26,876 @ $2.28) |
| Jun 6, 2022 | Grant Verstandig | Director | Buy | $54K (25,000 @ $2.14) |
| Jun 3, 2022 | Grant Verstandig | Director | Buy | $33K (15,000 @ $2.22) |
| Jun 2, 2022 | Grant Verstandig | Director | Buy | $107K (47,900 @ $2.23) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.